Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1976 | 2 |
2017 | 1 |
2019 | 1 |
2021 | 2 |
2024 | 1 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.
N Engl J Med. 2017 Jul 13;377(2):122-131. doi: 10.1056/NEJMoa1703643. Epub 2017 Jun 5.
N Engl J Med. 2017.
PMID: 28581356
Free PMC article.
Clinical Trial.
Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial.
Labori KJ, Bratlie SO, Andersson B, Angelsen JH, Biörserud C, Björnsson B, Bringeland EA, Elander N, Garresori H, Grønbech JE, Haux J, Hemmingsson O, Liljefors MG, Myklebust TÅ, Nymo LS, Peltola K, Pfeiffer P, Sallinen V, Sandström P, Sparrelid E, Stenvold H, Søreide K, Tingstedt B, Verbeke C, Öhlund D, Klint L, Dueland S, Lassen K; Nordic Pancreatic Cancer Trial-1 study group.
Labori KJ, et al. Among authors: klint l.
Lancet Gastroenterol Hepatol. 2024 Mar;9(3):205-217. doi: 10.1016/S2468-1253(23)00405-3. Epub 2024 Jan 15.
Lancet Gastroenterol Hepatol. 2024.
PMID: 38237621
Clinical Trial.
Item in Clipboard
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication.
Miles D, Ciruelos E, Schneeweiss A, Puglisi F, Peretz-Yablonski T, Campone M, Bondarenko I, Nowecki Z, Errihani H, Paluch-Shimon S, Wardley A, Merot JL, Trask P, du Toit Y, Pena-Murillo C, Revelant V, Klingbiel D, Bachelot T; PERUSE investigators.
Miles D, et al.
Ann Oncol. 2021 Oct;32(10):1245-1255. doi: 10.1016/j.annonc.2021.06.024. Epub 2021 Jul 2.
Ann Oncol. 2021.
PMID: 34224826
Free article.
Clinical Trial.
Item in Clipboard
Real world data on adjuvant treatment of older HER2-positive breast cancer patients - A single institution experience through 8 years.
Klint L, Kovács A, Rönnerman E, Linderholm B.
Klint L, et al.
Cancer Treat Res Commun. 2021;28:100430. doi: 10.1016/j.ctarc.2021.100430. Epub 2021 Jul 7.
Cancer Treat Res Commun. 2021.
PMID: 34273877
Free article.
Item in Clipboard
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE).
Bachelot T, Ciruelos E, Schneeweiss A, Puglisi F, Peretz-Yablonski T, Bondarenko I, Paluch-Shimon S, Wardley A, Merot JL, du Toit Y, Easton V, Lindegger N, Miles D; PERUSE investigators.
Bachelot T, et al.
Ann Oncol. 2019 May 1;30(5):766-773. doi: 10.1093/annonc/mdz061.
Ann Oncol. 2019.
PMID: 30796821
Free article.
Clinical Trial.
Item in Clipboard
[First field hospital in tent city now in a half-finished hotel building].
Klint L.
Klint L.
Tidskr Sver Sjukskot. 1976 Sep 9;43(16):42-3.
Tidskr Sver Sjukskot. 1976.
PMID: 1051074
Swedish.
No abstract available.
Item in Clipboard
[Scandinavian Red Cross: they rescued as many as possible].
Klint L.
Klint L.
Tidskr Sver Sjukskot. 1976 Aug 26;43(15):4-5.
Tidskr Sver Sjukskot. 1976.
PMID: 1051063
Swedish.
No abstract available.
Item in Clipboard
Cite
Cite